Samuel T. Wilkinson

Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3

Rachel Ochs-Ross, Ella Daly, Yun Zhang et al. · American Journal of Geriatric Psychiatry · 2019 · 453 citations

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

Maurizio Fava, Marlene P. Freeman, Martina Flynn et al. · Molecular Psychiatry · 2018 · 421 citations · Full text

Psychiatry, Mood Symptom, Medicine +13

Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression

Ewa Wajs, Leah Aluisio, Richard Holder et al. · The Journal of Clinical Psychiatry · 2020 · 261 citations · Full text

Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression

Amit Anand, Sanjay J. Mathew, Gerard Sanacora et al. · New England Journal of Medicine · 2023 · 227 citations

20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings

Taeho Greg Rhee, Mark Olfson, Andrew A. Nierenberg et al. · American Journal of Psychiatry · 2020 · 224 citations · Full text